La Jolla Pharmaceutical Announces FDA Approval of Giapreza
On December 21, La Jolla Pharmaceutical Company (LJPC) announced that the FDA approved its drug, Giapreza (angiotensin II). The drug can be used to increase blood pressure in adult patients suffering from septic shock or other distributive shock. La Jolla expects to have the drug available for patients in March 2018. Sonal detected the event […]